Azenta, Inc. (AZTA)
NASDAQ: AZTA · Real-Time Price · USD
38.18
+0.41 (1.09%)
Oct 13, 2026, 1:35 PM EDT - Market open
Azenta Market Cap
Azenta has a market cap or net worth of $1.67 billion as of October 13, 2026. It is the 7,580th most valuable company in the world and the 1,918th biggest in the United States. Its market cap has increased by 22.40% in one year.
Market Cap
1.67B
Enterprise Value
1.20B
1-Year Change
22.40%
Global Rank
Country Rank
#1,918 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, Azenta's market cap has increased from $156.00M to $1.67B, an increase of 972.18%. That is a compound annual growth rate of 8.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 1.67B | 9.86% |
| Dec 31, 2025 | 1.52B | -44.64% |
| Dec 31, 2024 | 2.75B | -38.94% |
| Dec 29, 2023 | 4.50B | 3.18% |
| Dec 30, 2022 | 4.37B | -43.01% |
| Dec 31, 2021 | 7.66B | 53.08% |
| Dec 31, 2020 | 5.00B | 65.34% |
| Dec 31, 2019 | 3.03B | 63.89% |
| Dec 31, 2018 | 1.85B | 11.18% |
| Dec 29, 2017 | 1.66B | 41.81% |
| Dec 30, 2016 | 1.17B | 62.52% |
| Dec 31, 2015 | 720.70M | -15.39% |
| Dec 31, 2014 | 851.80M | 22.12% |
| Dec 31, 2013 | 697.50M | 30.67% |
| Dec 31, 2012 | 533.80M | -21.43% |
| Dec 30, 2011 | 679.40M | 15.25% |
| Dec 31, 2010 | 589.50M | 6.85% |
| Dec 31, 2009 | 551.70M | 49.51% |
| Dec 31, 2008 | 369.00M | -63.14% |
| Dec 31, 2007 | 1.00B | -7.76% |
| Dec 29, 2006 | 1.09B | 91.38% |
| Dec 30, 2005 | 567.10M | -26.06% |
| Dec 31, 2004 | 767.00M | -13.40% |
| Dec 31, 2003 | 885.70M | 112.40% |
| Dec 31, 2002 | 417.00M | -48.51% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Teleflex | 5.33B |
| Stevanato Group | 5.25B |
| ICU Medical | 4.14B |
| Pulse Biosciences | 3.73B |
| Envista Holdings | 3.64B |
| Warby Parker | 3.31B |
| AtriCure | 2.91B |
| LeMaitre Vascular | 1.91B |